TCGX Acquisition Corp. (NASDAQ:TCGX) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (PIPE) Announced: US$160M · US$10 a share · Jefferies +3 Dealers: Jefferies (co-lead), TD Cowen (co-lead), Cantor, LifeSci Capital Buyers: TCGX; Viking Global Investors; ADAR1 Capital Management; BVF Partners; Samsara BioCapital; Vianti Capital Use of proceeds: Complete Phase 3 trials of elismetrep and submit an NDA, run a migraine prevention trial, and prepare for a potential U.S. launch | Oct 19, 2026 |
| Public offering of class A ordinary shares Closed: US$10 a share · Jefferies Dealers: Jefferies (lead) | Aug 6, 2026 |